Spoor Johan M. 4
4 · AzurRx BioPharma, Inc. · Filed Nov 14, 2017
Insider Transaction Report
Form 4
Spoor Johan M.
DirectorPresident and CEO
Transactions
- Exercise of In-Money
Common Stock
2017-11-10$1.00/sh+100,000$100,000→ 100,034 total - Exercise of In-Money
Options
2017-11-10−100,000→ 200,000 totalExercise: $1.00Exp: 2021-01-04→ Common Stock (100,000 underlying)
Holdings
- 39,851(indirect: By Children)
Common Stock
- 100,000
Options
Exercise: $4.48From: 2017-02-03Exp: 2027-02-03→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Held by the Reporting Person's mother for his minor children under the Uniform Transfers to Minors Act. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interests therein.
- [F2]Represents options granted to the Reporting Person by third parties.
- [F3]Immediately exercisable.